Treating prostate cancer patients with drugs that block hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study. While a 2006 report from members of the same study team found that treatment with gonadotropin-releasing hormone agonists increased the risk of diabetes and heart disease, the current study is the first to examine whether treatment actually increased heart disease-related deaths.

Gay and bisexual black men are less likely to be tested for prostate cancer than men of any other racial and ethnic backgrounds regardless of their sexual orientation.

Findings from one of the largest cancer chemoprevention trials ever conducted have concluded that selenium and vitamin E taken alone or in combination for an average of five and a half years did not prevent prostate cancer, according to a team of researchers coordinated by the Southwest Oncology Group and led by scientists at the University of Texas M. D. Anderson Cancer Center and Cleveland Clinic.

An ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer. Researchers found that noscapine, which has been used in cough medication for nearly 50 years, reduced tumor growth in mice by 60 percent and limited the spread of tumors by 65 percent without causing harmful side effects.

More than 95 per cent of men who took degarelix for prostate cancer saw their testosterone levels fall dramatically as early as three days after they started treatment, according to a new article.

In a major cancer prevention study, long-term supplementation with vitamin E or C did not reduce the risk of prostate or other cancers for nearly 15,000 male physicians.

Low-income men are more likely to present with advanced prostate cancers, most likely because they don’t receive screening services shown to reduce the diagnosis of later-stage cancers, a UCLA study found.

Researchers have concluded that there could be a link between the high expression of proinflammatory cytokines and high levels of prostate specific antigen (PSA) with the progression of prostate cancer.

Just under five per cent of the men who took part in the prostate cancer element of the USA’s largest ever cancer screening trial were diagnosed with the disease and the majority of those were picked up by screening programs.

Broccoli and other cruciferous vegetables have long been known to have anti-cancer benefits, and researchers have now found out why. One well-known anti-cancer chemical in broccoli, indole-3-carbinol, was found to inhibit the enzyme elastase, which is found at high levels in late-stage breast and prostate cancers. The discovery of this target will help to design better anti-cancer drugs and to target treatment to specific types of cancer, including late-stage breast and prostate cancers.